not tagged
not tagged
[]
ruiz et al. bdmard/tsdmard use in ra after breast cancer. low use, 15.5% on bdmard, 1.5% on tsdmard. stable use over last 10 years #acr22 abstr#0080 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC